Lawdragon Names Four Seeger Weiss Partners to 500 Global Plaintiff Lawyers

Seeger Weiss is pleased to announce that Lawdragon has recognized four of the firm’s partners, including co-founders Chris Seeger and Stephen Weiss, as well as partners David Buchanan and Jennifer Scullion, on the 2024 Lawdragon 500 Global Plaintiff Lawyers. According to Lawdragon, this year’s honorees “stand tall as a global movement bringing justice across borders. […]

April 5, 2024

Seeger Weiss is pleased to announce that Lawdragon has recognized four of the firm’s partners, including co-founders Chris Seeger and Stephen Weiss, as well as partners David Buchanan and Jennifer Scullion, on the 2024 Lawdragon 500 Global Plaintiff Lawyers. According to Lawdragon, this year’s honorees “stand tall as a global movement bringing justice across borders. Its defining ethos is revolutionary – business and other interests now largely transcend jurisdiction, so should no longer be able to cabin responsibilities into outdated strictures.”

Chris Seeger, co-founding partner of Seeger Weiss, is widely recognized as a highly innovative and accomplished plaintiff attorney. He has led some of the most complex, groundbreaking, and high-profile litigations in the U.S, at both the state and federal level. He received more MDL appointments than any other lawyer between 2016 and 2019 and currently serves in leadership roles in MDLs including the 3M Combat Arms Earplug Litigation, National Prescription Opiate Litigation, Philips CPAP, Bi-Level PAP, and Mechanical Ventilator Litigation, and Social Media Adolescent Addiction/Personal Injury Litigation.

Stephen Weiss, co-founding partner of Seeger Weiss, chairs the firm’s qui tam/whistleblower practice, representing relators in some of the nation’s largest and most notable cases, including the recent $10 million settlement in a whistleblower lawsuit against medical device company Stimwave. His diverse practice spans high-profile multidistrict litigations, arbitrations, and private business disputes across various legal disciplines, including qui tam/whistleblower, consumer products, insurance, agricultural, environmental, securities, employment, and property rights litigation.

Senior partner Dave Buchanan represents individual and corporate plaintiffs in state and federal courts throughout the country. Most recently, Dave was appointed as co-lead counsel for the Self-Funded Payer Track in the In re: Insulin Pricing Litigation. Dave served as the co-chair of the Plaintiffs Steering Committee as well as head of the discovery committee in the 3M earplugs litigation, where he represented hundreds of thousands of men and women in uniform who suffered hearing loss, tinnitus, and loss of balance due to faulty earplugs, the largest mass tort in American history. He also served on the plaintiffs’ executive committee in the NFL Concussion Litigation and was co-chair of discovery as well as lead counsel in several bellwether trials in the Vioxx Litigation.

For over two decades, partner Jennifer Scullion has led complex litigations, arbitrations, and appeals for U.S. and multinational clients in a wide array of areas, including antitrust, consumer fraud, communications, civil rights, and international bondholder disputes. Her experience includes multidistrict litigations, class actions, and federal regulatory proceedings. Currently, Jen is a member of the Plaintiffs’ Executive Committee, Settlement Committee, Manufacturers’ Committee, and Law & Briefing Committee in the National Prescription Opiate Litigation, multidistrict litigation prosecuting RICO, public nuisance and related claims on behalf of local governments and co-lead counsel for negotiation class. She also continues to be a key member of the plaintiffs’ team leading efforts to hold social media companies accountable for products endangering the lives of children in the Social Media Harm litigation.

Lawdragon’s selection methodology is performed through independent journalistic research and submissions. Decisions are carefully made based on factors including research of top verdicts and settlements, peer recognition, and interviews with lawyers nationwide. The selection methodology can be found here. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.

Related News

May 13, 2024
Seeger Weiss, Chris Seeger Named Elite Trial Lawyers Plaintiff Firm of the Year and Plaintiff Attorney of the Year Finalists; Parvin Aminolroaya Wins Elite Women of the Plaintiffs Bar Award

Seeger Weiss is pleased to announce that the firm and several of its partners have won or are finalists for multiple 2024 National Law Journal Elite Trial Lawyers Awards. Seeger Weiss was named a finalist for: Plaintiffs Firm of the Year Environmental Protection Practice Group of the Year Government Representation Practice Group of the Year […]

Read More
May 9, 2024
Seeger Weiss Reaches $1.1 Billion Personal Injury and Medical Monitoring Settlement in Philips CPAPs, Bi-PAPs, and Ventilators Litigation

Seeger Weiss founder and court-appointed co-lead counsel Chris Seeger secured a nearly $1.1 billion settlement in the Philips Recalled CPAP, Bi-Level Pap, and Mechanical Ventilator Products Litigation. The agreement provides $1.075 billion to compensate patients who suffered injuries while using recalled Philips devices and also includes $25 million to cover the cost of medical monitoring […]

Read More
May 9, 2024
Seeger Weiss Partner Parvin Aminolroaya Appointed Co-lead Counsel In Ozempic Litigation

RIDGEFIELD PARK, NJ — Seeger Weiss is pleased to announce that partner Parvin K. Aminolroaya has been appointed to serve as plaintiffs’ co-lead counsel in the Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation by the honorable Judge Gene E. K. Pratter. This litigation consolidates dozens of lawsuits against drugmakers Novo Nordisk and Eli […]

Read More